EcoDrugPlus

Cyclin Dependent Kinase 6

Ensembl ID : ENSLACG00000004106
Gene Symbol: CDK6
4 Cross references
201 Possible Orthologues:

Cyclin Dependent Kinase 7

Ensembl ID : ENSLACG00000016088
Gene Symbol: CDK7
4 Cross references
218 Possible Orthologues:

Cyclin Dependent Kinase 9

Ensembl ID : ENSLACG00000017060
Gene Symbol: CDK9
4 Cross references
207 Possible Orthologues:

Cysteinyl Leukotriene Receptor 1

Ensembl ID : ENSLACG00000003113
Gene Symbol: CYSLTR1
2 Cross references
173 Possible Orthologues:

Cytidine Deaminase

Ensembl ID : ENSLACG00000022185
Gene Symbol: CDA
4 Cross references
224 Possible Orthologues:

Cytochrome P450 3a24-Like

Ensembl ID : ENSLACG00000003781
Gene Symbol: LOC102357335
1 Cross references
743 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSLACG00000022642
Gene Symbol: LOC102365730
3 Cross references
743 Possible Orthologues:

Cytochrome P450 3a27-Like

Ensembl ID : ENSLACG00000022316
Gene Symbol: LOC102359382
1 Cross references
743 Possible Orthologues:

Cytochrome P450 Family 17 Subfamily A Member 1

Ensembl ID : ENSLACG00000004894
Gene Symbol: CYP17A1
2 Cross references
210 Possible Orthologues:

Cytochrome P450 Family 19 Subfamily A Member 1

Ensembl ID : ENSLACG00000009360
Gene Symbol: CYP19A1
4 Cross references
315 Possible Orthologues:

Cytochrome P450 Family 26 Subfamily A Member 1

Ensembl ID : ENSLACG00000015829
Gene Symbol: CYP26A1
4 Cross references
207 Possible Orthologues:

Cytochrome P450 Family 46 Subfamily A Member 1

Ensembl ID : ENSLACG00000015747
Gene Symbol: CYP46A1
4 Cross references
258 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).